Marangos, Markos
Ioannou, Petros
Senn, Laurence
Spiliopoulou, Anastasia
Tzalis, Sotiris
Kolonitsiou, Fevronia
Valta, Maria
Kokkini, Sofia
Pagani, Jean-Luc
Stafylaki, Dimitra
Paliogianni, Fotini
Fligou, Fotini
Kofteridis, Diamantis P.
Lamoth, Frédéric
Papadimitriou-Olivgeris, Matthaios
Funding for this research was provided by:
University of Lausanne
Article History
Received: 10 January 2024
Accepted: 20 February 2024
First Online: 12 March 2024
Declarations
:
: Frederic Lamoth declares research grants from Funginos, Novartis, Pfizer and Merck, and speaker honoraria from Gilead. All contracts were made with and fees paid to his institution (LUH). The remaining authors have no competing interests to declare that are relevant to the content of this article.
: The study adhered to the Declaration of Helsinki and was approved by the institutional ethics review boards; ethics committee of UGHP on 22.02.2022 (109.2022), ethics committee of UGHH on 27.06.2022 (643.2022), and ethics committee of Canton of Vaud on 07.10.2022 (2022-01532).
: Due to the retrospective nature of the study, all ethics committee waived the need of informed consent to participate. However, patients at LUH were excluded if they had previously refused to permit the use of their data for research purposes.
: Due to the retrospective nature of the study, all ethics committee waived the need of informed consent to participate. However, patients at LUH were excluded if they had previously refused to permit the use of their data for research purposes.